STOCK TITAN

DUKE Robotics (DUKR) Form 4 Filings

DUKR NASDAQ

Here are the Form 4 insider transactions from DUKE Robotics Corp. (DUKR) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow DUKR and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full DUKR filings page.

Rhea-AI Summary

DUKE Robotics Corp. Chief Technology Officer Vadim Maor acquired 28,000 options to purchase common stock on October 5, 2026, at an exercise price of $5.45 per share. One-third of the options vest on each of the first and second anniversaries of the grant date, with the remaining one-third vesting on the third anniversary. The options expire October 5, 2032.

Rhea-AI Summary

DUKE Robotics Corp. director Erez Nachtomy received a direct award of 28,000 options to purchase common stock. The options have a $5.45 exercise price and expire October 5, 2032. 9,333 options vest on the first anniversary of the grant; the remaining options vest in quarterly installments over the following 24 months.

Rhea-AI Summary

DUKE Robotics Corp. CEO Yiftach Kleinman acquired an award of options to purchase 53,600 common shares on October 5, 2026. The options have an exercise price of $5.45 per share and expire October 5, 2032.

Rhea-AI Summary

DUKE Robotics Corp. Chief Financial Officer Avi Levin was granted 35,000 options to purchase common stock on October 5, 2026. The options have a $5.45 exercise price and expire October 5, 2032. They vest partly on the first anniversary of the grant date, with the remaining options vesting quarterly over the following 24 months.

Rhea-AI Summary

DUKE Robotics Corp. chief executive officer Balucka Yossef exercised stock options to acquire 18,000 shares of common stock. On the transaction date, the options were exercised at an exercise price of $0.0001 per share, converting the entire option award into common shares.

Following the transaction, Yossef directly holds 18,000 shares of DUKE Robotics Corp. common stock and no longer holds options under this particular award, which was scheduled to expire on July 13, 2026 and was exercised in full before expiration in accordance with its terms.

Rhea-AI Summary

DUKE Robotics Corp. director Antebi Eran received an option grant for 4,000 shares of common stock at an exercise price of $7.88 per share. The option was fully unheld before this award, so his post-transaction derivative holdings in this grant are 4,000 options. The option vests in three equal annual installments beginning on March 10, 2027, and expires on March 10, 2032. This is a compensation-related award, not an open-market trade.

Rhea-AI Summary

Zakai Shlomo reported acquisition or exercise transactions in this Form 4 filing.

DUKE Robotics Corp. chief financial officer Zakai Shlomo received a grant of options to purchase 10,000 shares of common stock, exercisable at $7.88 per share. The option expires on March 10, 2032 and vests in three equal annual installments beginning on March 10, 2027.

Rhea-AI Summary

DUKE Robotics Corp. director Golan Keren Gousman received an option grant for 4,000 shares of common stock at an exercise price of $7.88 per share, expiring on March 10, 2032. The option vests in three equal annual installments beginning on March 10, 2027.

Rhea-AI Summary

DUKE Robotics Corp. reported that Chief Technology Officer Maor Vadim received a grant of options to purchase 4,000 shares of common stock at an exercise price of $7.88 per share. These options are a form of equity compensation rather than an open‑market trade.

The options expire on March 10, 2032 and vest in three equal annual installments beginning on March 10, 2027. After this award, Vadim holds options for 4,000 underlying shares directly, with no sales or exercises reported in this filing.

Rhea-AI Summary

DUKE Robotics Corp. chief executive officer Balucka Yossef received a grant of options to purchase 16,000 shares of common stock at an exercise price of $7.88 per share. The options vest in three equal annual installments beginning on March 10, 2027 and expire on March 10, 2032. Following the grant, he holds 16,000 options directly.

Rhea-AI Summary

DUKE Robotics Corp. director Nachtomy Erez received an option grant covering 16,000 shares of common stock at an exercise price of $7.88 per share. The option vests in three equal annual installments beginning on March 10, 2027, and expires on March 10, 2032. Following this grant, Erez holds options on 16,000 shares directly.